Search This Blog

Saturday, November 7, 2015

FDA Accepts Amgen's New Drug Application For Novel Intravenous Calcimimetic Etelcalcetide

Amgen - Investors - RSS Content

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.